Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) shares rose 2.5% on Wednesday . The stock traded as high as $0.61 and last traded at $0.58. Approximately 35,845 shares were traded during mid-day trading, an increase of 147% from the average daily volume of 14,486 shares. The stock had previously closed at $0.57.
Spectral Medical Stock Performance
The stock has a market cap of $165.25 million, a price-to-earnings ratio of -8.28 and a beta of 0.54. The stock’s 50-day simple moving average is $0.49 and its two-hundred day simple moving average is $0.43.
About Spectral Medical
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
- Five stocks we like better than Spectral Medical
- Stock Dividend Cuts Happen Are You Ready?
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Golden Cross Stocks: Pattern, Examples and Charts
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
